Moedas / WINT
WINT: Windtree Therapeutics Inc
0.11
USD
0.37
(77.08%)
A taxa do WINT para hoje mudou para -77.08%. Paralelamente, o preço mais baixo no mercado atingiu 0.10 e o mais alto foi 0.50.
Veja a dinâmica do par de moedas Windtree Therapeutics Inc. As cotações em tempo real ajudam a reagir rapidamente aos movimentos do mercado. Ao alternar entre os diferentes períodos de tempo, você pode monitorar tendências e movimentos de preços por minuto, hora, dia, semana ou mês. Use estas informações para prever os movimentos do mercado e tomar decisões de negociação informadas.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
WINT Notícias
- Windtree Therapeutics stockholders approve share increases and reverse split
- U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.04%
- Windtree Therapeutics to be delisted from Nasdaq, will trade over the counter
- Windtree sees major reduction in preferred stock as investors redeem shares
- Why Are Public Companies Ammassing ETH, XRP, SOL, BNB Instead Of Just Bitcoin?
- Windtree Therapeutics stock rises after securing $500M equity line for BNB strategy
- Windtree Therapeutics commits up to $700 million for BNB purchases
- Windtree Therapeutics secures up to $520 million for BNB cryptocurrency purchases
- Windtree partners with Kraken for BNB crypto treasury strategy
- Dow Jumps Over 100 Points; PepsiCo Posts Upbeat Earnings - GameSquare Holdings (NASDAQ:GAME), CareDx (NASDAQ:CDNA)
- Why Sarepta Therapeutics Shares Are Trading Higher By 34%; Here Are 20 Stocks Moving Premarket - ReAlpha Tech (NASDAQ:AIRE), Above Food Ingredients (NASDAQ:ABVE)
- Windtree Therapeutics enters $60 million deal to launch BNB crypto strategy
- Windtree Therapeutics enters $60 million BNB crypto treasury deal
- Why Datavault AI Shares Are Trading Higher By 7%; Here Are 20 Stocks Moving Premarket - Autozi Internet Tech (NASDAQ:AZI), Above Food Ingredients (NASDAQ:ABVE)
- Windtree Therapeutics receives U.S. patent for istaroxime heart failure drug
- Windtree reaches interim enrollment goal for istaroxime shock study
- Windtree Advances Lower Cost Manufacturing of PHEXXI, Evofem’s Hormone-Free, On-Demand Prescription Contraceptive Gel
- Istaroxime shows positive results in cardiogenic shock study
- Titan Environmental to be acquired by Windtree Therapeutics
- Windtree Therapeutics Stock Is Volatile This Week: What's Going On? - Windtree Therapeutics (NASDAQ:WINT)
- Windtree Therapeutics receives $7M offer for oncology platform
- Windtree Therapeutics to accept cryptocurrency payments
- WINT stock touches 52-week low at $0.7 amid steep annual decline
- WINT stock touches 52-week low at $0.75 amid steep annual decline
Faixa diária
0.10
0.50
Faixa anual
0.09
7.90
- Fechamento anterior
- 0.48
- Open
- 0.48
- Bid
- 0.11
- Ask
- 0.41
- Low
- 0.10
- High
- 0.50
- Volume
- 15.898 K
- Mudança diária
- -77.08%
- Mudança mensal
- -83.33%
- Mudança de 6 meses
- -96.57%
- Mudança anual
- -98.61%
08 setembro, segunda-feira
19:00
USD
- Atu.
- Projeç.
- $11.14 bilh
- Prév.
- $7.37 bilh